Leavitt Chase C. has bought 15,000 shares of Oncternal Therapeutics, Inc. [ONCT] at $0.29 a share.
Oncternal Therapeutics, Inc. [ONCT] disclosed in an SEC Form 4 submission Wednesday, April 12, 2023 that the deal increased Leavitt Chase C.'s holding in the company to 96,901.
Oncternal Therapeutics, Inc. [ONCT] is a Pharmaceutical Preparations company based in Delaware.
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.